A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas
Clinical trial NCT04089449 · COMPLETED
Trial details
- NCT number
- NCT04089449
- Sponsor
- Prelude Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2023-03-28
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.